Remote lifestyle modification to control risk factors for secondary prevention in ischemic heart disease

Effects of remote lifestyle intervention to control coronary risk factors in patients after percutaneous coronary intervention: a pilot non-randomized controlled trial - Remote lifestyle intervention for patients after percutaneous coronary intervention

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039007

Enrollment

Registered

2019-12-27

Start date

2021-10-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome, Stable angina pectoris

Interventions

Definition Intervention: Receive remote lifestyle intervention using web system after discharge Note Intervention: Receive remote lifestyle intervention using web system for around 22 weeks after

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients underwent percutaneous coronary intervention (PCI) for acute coronary syndrome or stable angina pectoris; hope to participate in remote lifestyle intervention after discharge without a plan to participate in outpatient cardiac rehabilitation; do not have exercise (exercise for 30 min or over including brisk walk per set, 3 times or over per week) habit before PCI; provide written informed consent

Exclusion criteria

Exclusion criteria: Patients showing abnormal cardiovascular response during exercise; not using the Internet at home; not capable of sending an email by smartphone or tablet-type device; not capable of using computer or IoT device due to visual impairment or mental disorder; receiving hemodialysis; considered inappropriate for participating in remote lifestyle intervention by doctor-in-charge

Design outcomes

Primary

Measure	Time frame
-Dropout rate -Compliance rate of intervention protocol -Evaluation period: around 14-week after exercise tolerance test	—

Secondary

Measure	Time frame
-Systolic blood pressure, diastolic blood pressure -Low-density lipoprotein cholesterol, Non High-density lipoprotein cholesterol, High-density lipoprotein cholesterol, Triglyceride -HbA1c, Fasting blood sugar or Blood sugar 2 hours after eating -Peak oxygen uptake -Reduction of body weight (among patients with body mass index >/=24) -Moderate to vigorous physical activity -Health-related quality of life -Evaluation period: around 14-week after exercise tolerance test	—

Measure

Time frame

-Systolic blood pressure, diastolic blood pressure -Low-density lipoprotein cholesterol, Non High-density lipoprotein cholesterol, High-density lipoprotein cholesterol, Triglyceride -HbA1c, Fasting blood sugar or Blood sugar 2 hours after eating -Peak oxygen uptake -Reduction of body weight (among patients with body mass index >/=24) -Moderate to vigorous physical activity -Health-related quality of life -Evaluation period: around 14-week after exercise tolerance test

—

Countries

Japan

Contacts

Public ContactTakuji Adachi

Nagoya University Graduate School of Medicine (Health Sciences)

t.adachi@met.nagoya-u.ac.jp052-719-1876

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026